Youtor
Gilead signs agreements to facilitate access to HIV prevention drug
>> YOUR LINK HERE: ___ http://youtube.com/watch?v=wiMf3-3uSm8
Gilead signs agreements to facilitate access to HIV prevention drug • The move aligns with Gilead's strategy to ensure the availability of lenacapavir worldwide for PrEP. • Gilead Sciences has announced the signing of voluntary licencing agreements with six generic pharmaceutical manufacturers to facilitate access to lenacapavir, a potential human immunodeficiency virus (HIV) prevention drug, in 120 resource-limited and high-incidence nations. • The company signed agreements with Dr. Reddy’s Laboratories, Eva Pharma, Emcure, Ferozsons Laboratories, Mylan, a subsidiary of Viatris, and Hetero. • Thank you for watching the video, wish you health and happiness! • Subscribe to the channel at: https://goo.gl/iz6xA4 • ▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬ • If you have any questions, please contact us by email: [email protected] • Sincerely thank you! • ▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬ • Sign up: / @hivaidsprevention • Facebook: / hivaids2024 • Twitter: / daubenh • Gmail: [email protected]
#############################
